000028192 000__ 03368cam\a22005055i\4500
000028192 001__ 28192
000028192 003__ SzGeWIPO
000028192 005__ 20231025175136.0
000028192 008__ 190906s2011\\\\sz\\\\\\r\\\\\000\0\eng\d
000028192 020__ $$a9789280521627
000028192 022__ $$a2790-7007 (Print)
000028192 022__ $$a2790-7015 (Online)
000028192 0247_ $$a10.34667/tind.28192$$2doi
000028192 035__ $$aWIPO/PUB/946/1/EN
000028192 035__ $$a(OCoLC)1161010575
000028192 040__ $$aSzGeWIPO$$beng$$erda$$cSzGeWIPO$$dCaBNVSL
000028192 041__ $$aeng
000028192 24500 $$aPatent Landscape Report on Ritonavir.
000028192 264_1 $$aGeneva, Switzerland :$$bWorld Intellectual Property Organization,$$c2011.
000028192 300__ $$a105 pages ;$$c[28] cm.
000028192 336__ $$atext$$btxt$$2rdacontent
000028192 337__ $$aunmediated$$bn$$2rdamedia
000028192 338__ $$avolume$$bnc$$2rdacarrier
000028192 4901_ $$aPatent Landscape Reports
000028192 516__ $$aPrint publication.
000028192 520__ $$aThis report is dedicated to Ritonavir - an antiretroviral drug used to treat HIV infection and AIDS. A major goal of the report is to highlight the technology timeline for Ritonavir from the first filing of this compound to the present filings. It identifies a number of innovation tracks derived from the first Ritonavir patent document. The report also includes an analysis of statistical trends. A comprehensive explanation of the search methodology and history (including all search queries), and of the evaluation of the search results is included and illustrates how patent information can be retrieved and exploited in the area of pharmaceuticals.
000028192 650_0 $$aSolar collectors$$xPatents.
000028192 650_0 $$aPatents.
000028192 650_4 $$aPatents
000028192 650_4 $$aOTHER INDUSTRIAL PROPERTY RIGHTS : WINE APPELLATIONS
000028192 7102_ $$aWorld Intellectual Property Organization.
000028192 77418 $$aPCT
000028192 830_0 $$aPatent Landscape Reports.
000028192 8564_ $$94637f286-e685-4581-96b5-eb07b72c0c50$$s1241801$$zComplete document (PDF)$$uhttps://tind.wipo.int/record/28192/files/wipo_pub_946.pdf
000028192 8564_ $$9325d4fa3-5099-407b-8361-b0df845927e9$$s130080$$zExecutive summary (PDF)$$uhttps://tind.wipo.int/record/28192/files/wipo_pub_946_1-tech1.pdf
000028192 8564_ $$9d0a53f20-8abe-4556-934d-7649b2505e72$$s170686$$zAppendix 1 - Innovation Tracks: Liquid oral dosage forms (PDF)$$uhttps://tind.wipo.int/record/28192/files/wipo_pub_946_1-tech2.pdf
000028192 8564_ $$9ce36527a-6e82-43d9-80b9-d0ba9b901641$$s145992$$zAppendix 2 - Innovation Tracks: Synthesis of Ritonavir (PDF)$$uhttps://tind.wipo.int/record/28192/files/wipo_pub_946_1-tech3.pdf
000028192 8564_ $$94b9e6382-b02a-4074-99af-3288aafb55c1$$s174495$$zAppendix 3 - Innovation Tracks: Structural considerations and polymorphs (PDF)$$uhttps://tind.wipo.int/record/28192/files/wipo_pub_946_1-tech4.pdf
000028192 8564_ $$978fc96da-a3c3-41e7-847a-f70d5513bfd5$$s133190$$zAppendix 4 - Innovation Tracks: Solid dosage forms (PDF)$$uhttps://tind.wipo.int/record/28192/files/wipo_pub_946_1-tech5.pdf
000028192 8564_ $$9347639f5-8f5c-494d-9b6e-058a59c0f7db$$s108411$$zAppendix 5 - Innovation Tracks: Prodrugs of Ritonavir (PDF)$$uhttps://tind.wipo.int/record/28192/files/wipo_pub_946_1-tech6.pdf
000028192 8564_ $$9472b83d5-8ff8-4490-a85f-f9da87e40f2a$$s12647424$$zDatabase of patent families (XLSX)$$uhttps://tind.wipo.int/record/28192/files/wipo_pub_946_1-tech7.xls
000028192 8564_ $$9b6807374-e96b-40da-abbc-85479403ac8d$$s2025139$$zSample citation map of WO1994014426 key patent (PDF)$$uhttps://tind.wipo.int/record/28192/files/wipo_pub_946_1-tech8.pdf
000028192 8564_ $$91ab0799c-211a-4f82-a2b6-67b729ac38d5$$s140066$$zInfographic (PDF)$$uhttps://tind.wipo.int/record/28192/files/wipo_pub_946_1-tech9.pdf
000028192 901__ $$aWIPO/PUB/946/1
000028192 902__ $$a230_en
000028192 903__ $$aPatent landscape reports
000028192 904__ $$aBook
000028192 909CO $$ooai:tind.wipo.int:28192$$pWIPOPUB
000028192 980__ $$aWIPOPUB$$aPLR